Zepp Health (ZEPP) Cash & Equivalents (2016 - 2026)

Zepp Health (ZEPP) has reported Cash & Equivalents for 11 consecutive years, with $52.4 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 68558954.81% year-over-year to $52.4 billion; the TTM figure through Mar 2026 stood at $52.4 billion (up 68558954.81% YoY), while the FY2025 annual figure was $57046.0 billion, up 62640315.51% from the prior year.
• Cash & Equivalents slipped to $52.4 billion in Q1 2026 per ZEPP's latest filing, from $57046.0 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $131809.1 billion in Q4 2023 and bottomed at $76429.0 in Q1 2025.
• Historically, Cash & Equivalents has averaged $11168.1 billion across 5 years, with a median of $61.7 billion in 2025.
• Annual changes were most pronounced in 2023 — Cash & Equivalents jumped 105731351.96% — and 2025, when it sank 100.0%.
• Zepp Health's Cash & Equivalents stood at $124.7 million in 2022, then soared by 105731351.96% to $131809.1 billion in 2023, then tumbled by 100.0% to $91.1 million in 2024, then soared by 62640315.51% to $57046.0 billion in 2025, then sank by 99.91% to $52.4 billion in 2026.
• Business Quant data shows ZEPP's Cash & Equivalents at $52.4 billion in Q1 2026, $57046.0 billion in Q4 2025, and $61.7 billion in Q3 2025.